Mitochondrial Dysfunction in TDP-43 Knockout HeLa Cells

Overview

Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD) are all classified as neurodegenerative disorders. In many neurodegenerative diseases, TDP-43 leaves the nucleus and can be found aggregating in the cytoplasm of a cell. Mitochondria were selected as a target in this experiment because depolarization of the mitochondria's membrane potential can lead to apoptosis, linking this organelle to many neurodegenerative disorders. The first goal is to investigate whether mitochondrial clustering in TDP-43 knockout cells is due to the TDP-43 depletion from the nucleus. The second goal is to determine if mitochondrial clustering leads to mitochondrial dysfunction in TDP-43 knockout cells. The third goal is to identify mitochondrial genes that are differently expressed in HeLa knock-out cells compared to wild-type cells. When comparing the WT and TDP-43 KO HeLa cells, we observed a clustering of the mitochondria as well as a fragmentation of the mitochondrial network, visualizing through microscopy. Our studies showed that TDP-43 was able to successfully rescue the splicing in the TDP-43 KO HeLa cells after transfection; however, mutants of TDP-43 were not able to rescue this splicing. This was shown by performing a western blot and staining with NUP188 and EGFP. Membrane potential of the KO cells was lower than that of the WT, this depolarization can trigger neuronal death. Flow cytometry showed the membrane depolarization through staining WT and TDP-43 KO HeLa cells with TMRM. Our results supported our hypothesis as many mitochondrial genes and characteristics were differently expressed with the absence of TDP-43 splicing.

Competition history

ISEF 2023 Cellular and Molecular Biology · Entry CELL028 · Dallas, Texas, United States Affiliated fair in FL, United States of America

Mitochondrial Dysfunction in TDP-43 Knockout HeLa Cells

Overview

Competition history

Resources

Related projects

Loss of TDP43 in Motor Neurons Leads to Deficits in Axonal RNAs in an Animal Model of ALS

Investigating the Role of Mutant CHCHD10 in ALS Pathogenesis Through Mouse Models

A Differential Gene Expression and Alternative Splicing Analysis of ALS-Causing Mutations

Regulation of Insulin Pathway Signaling in a Drosophila Model of ALS

In Amyotrophic Lateral Sclerosis (ALS) Patient Tissue, UG Rich RNA Is Not Preferentially Soluble as Predicted

Intronic RNA as a Therapeutic Target in Neurodegeneration: A Multipronged Study of RNA Lariat Debranching Enzyme DBR1

Investigation of Autophagy in Huntington's Disease using a Mutant Huntingtin Knock-in Striatal Cell Line

UG-Rich RNA Is Key to Alleviating Neurodegeneration in a Drosophila Model of Amyotrophic Lateral Sclerosis (ALS)

Browse more like this